Institutional owners may consider drastic measures as Puma Biotechnology, Inc.'s (NASDAQ:PBYI) recent US$28m drop adds to long-term losses - Simply Wall St News
Puma fallen nach schwächerer Gewinnprognose als erwartet - Bloomberg
Making Elliott Wave Sense of Puma Stock's Recovery - EWM Interactive
Puma's Retro Sneakers Lose Traction as Consumers Look to Runway - Bloomberg